---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-022077"
form_type: "8-K"
ticker: null
cik: "0001444307"
company_name: "ONCOSEC MEDICAL Inc"
filed_at: "2023-06-22T23:59:59+00:00"
generated_at: "2026-06-13T18:55:36.996880+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# OncoSec receives Nasdaq delisting notice after Chapter 7 filing; trading suspended June 26

## Summary
- Nasdaq Staff determined to delist OncoSec due to Chapter 7 bankruptcy filing (June 14) and public interest concerns.
- Company failed to meet minimum $2.5M stockholders' equity (Rule 5550(b)(1)) and bid price above $1.00 (Rule 5550(a)(2)).
- Trading of common stock (ONCS) will be suspended at opening on June 26, 2023; Form 25-NSE to follow.
- Company does not intend to appeal the Staff's determination.

## SEC filing metadata
- accession: 0001493152-23-022077
- form_type: 8-K
- cik: 0001444307
- company_name: ONCOSEC MEDICAL Inc
- filed_at: 2023-06-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1444307/000149315223022077/0001493152-23-022077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1444307/000149315223022077/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-022077
- JSON: https://secwatch.observer/filing/0001493152-23-022077.json
- Plain text: https://secwatch.observer/filing/0001493152-23-022077.txt

## Key facts
- Listing & Compliance Notices
  ONCOSEC MEDICAL Inc received a nasdaq delisting notice notice regarding other (rules 5550(b)(1), 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Rules: 5550(b)(1), 5550(a)(2)
  source text: June 15, 2023, the Chapter 7 bankruptcy trustee (“Trustee”) for OncoSec Medical Incorporated (the “Company”) received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company and the Trustee that the Staff has, in accordance with Listing Rules 5101, 5110(b), and IM-5101-1, determined that the Company’s securities will be delisted from Nasdaq based on the following factors: (i) on June 14, 2023, the Company filed for protection under Chapter 7 of the U.S. Bankruptcy Code (the “Chapter 7 Filing”) and the associ
  evidence_url: https://www.sec.gov/Archives/edgar/data/1444307/000149315223022077/0001493152-23-022077-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.